Related Experiment Video

Updated: Dec 12, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.0K

New developments in adult congenital heart disease

B J Bouma1, G T Sieswerda2, M C Post3

  • 1Department of Cardiology, Amsterdam UMC, University of Amsterdam, Heart Center, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands. b.j.bouma@amsterdamumc.nl.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|August 12, 2020
PubMed

Insights

Advances in treating congenital heart disease (CHD) have increased survival, but late complications remain a challenge. Continuous innovation in diagnostics and care is crucial for improving outcomes in adults with CHD.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Adult Congenital Heart Disease

Background:

  • Congenital heart disease (CHD) affects 0.8% of live births, with survival rates exceeding 95% into adulthood due to improved treatments.
  • Adult survivors of CHD face significant risks of late complications, including heart failure, pulmonary hypertension, arrhythmias, aneurysms, and endocarditis, impacting morbidity and mortality.
  • Recent innovations have transformed the management landscape for adult CHD patients.

Purpose of the Study:

  • To review recent advancements in the diagnosis and treatment of adult congenital heart disease.
  • To highlight the evolving challenges and improved outcomes for adult CHD patients.
  • To emphasize the importance of specialized care, multidisciplinary collaboration, and ongoing research in managing adult CHD.

Main Methods:

  • Review of innovations in diagnostic tools, including MRI, biomarkers, e-health, and 3D visualization.
  • Description of the shift towards specialized centers with multidisciplinary consultations for diagnosis and intervention.
  • Overview of refined surgical and percutaneous interventions and evolving research methodologies from case series to global networks.

Main Results:

  • Significant improvements in diagnostic accuracy and visualization techniques for adult CHD.
  • Enhanced care models through specialized centers and multidisciplinary teams.
  • Refined interventional strategies leading to reduced burden of congenital malformations.

Conclusions:

  • Despite improved survival, adults with CHD continue to face substantial risks of early mortality and morbidity.
  • Global collaboration, continuous education, and innovation in diagnostic and therapeutic approaches are essential for improving the long-term outlook for adult CHD patients.
  • The field of adult CHD is rapidly evolving, necessitating ongoing adaptation and advancement in care strategies.

Keywords:
AdultsCardiac surgeryCongenital heart diseaseGUCHInterventionsNew developments

More Related Videos

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents06:33

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents

Published on: September 21, 2021

2.7K
Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.0K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
190
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
293
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
244
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
554
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
155
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
151